Statistics
Publications
7
Citations
217
H-Index
7
Active since
2019
Marcus Borenäs is an author at University of Gothenburg specializing in oncology, molecular oncology, and alk inhibition.
Publications per year
2019–2024
7
7
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Marcus Borenäs, Ganesh Umapathy, Wei‐Yun Lai et al. · The EMBO Journal · 2021 · 64 citations · Full text
Medicine, Oncology, Pharmacology +17
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells
Diana Cervantes-Madrid, Joanna Szydzik, Dan E. Lind et al. · Scientific Reports · 2019 · 28 citations · Full text
Medicine, Oncology, Pharmacology +17
Niloufar Javanmardi, Susanne Fransson, Anna Djos et al. · Genes Chromosomes and Cancer · 2019 · 27 citations
1–5 of 7